MDAI: Spectral AI, Inc. EV/EBITDA Multiple

Corporate emblem and logo of Spectral AI, Inc. (MDAI)

Spectral AI, Inc. (MDAI) develops cloud-based AI tools for wound and burn analysis, ensuring seamless global deployment and subscription-based revenue. However, the business faces stringent FDA oversight and the necessity of proving algorithmic accuracy to medical professionals. Amidst the broader digitalization trend, share price volatility reflects a current EV/EBITDA ratio of 0.00, confirming the model's resilience during this growth period.

spectral-ai.com - MDAI Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/10/2026)

Summary analytical data breakdowns for Spectral AI Inc. (MDAI)

- stock price and consensus target price:
Stock Quotes Spectral AI|MDAI - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Spectral AI, Inc.|MDAI - Company Buyout Price
- issuer book value statistics:
Book Value per Share Spectral AI|MDAI - Company Net Assets|Market Cap to Net Assets Ratio spectral-ai.com|MDAI - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Spectral AI, Inc.|MDAI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Spectral AI, Inc.|MDAI - Company Cumulative Debt|Debts to Book Capitalization Spectral AI, Inc.|MDAI - Company Long-Term Indebtedness|Company Short-Term Debts Spectral AI|Quick Ratio spectral-ai.com
- financial results and valuation multiples details:
MDAI - Net Income|Projected Future Earnings Spectral AI, Inc.|MDAI - P/E Multiple|Future Price to Earnings Spectral AI|MDAI - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Spectral AI, Inc.|MDAI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Spectral AI|MDAI - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months spectral-ai.com|MDAI - Net earnings per share change in current year|Expected earnings per share growth for next year Spectral AI, Inc.
Initial company analysis:Spectral AI MDAI
Original product of Spectral AI Inc.

This indicator determines the intersection of market expectations and the actual value of assets by comparing enterprise value, accounting for debt and taxes, with operating profit. An analysis of the EV/EBITDA ratio allows for an assessment of overpayment risk, which for Spectral AI, Inc. (MDAI) confirms financial stability amid steady cash flows from the implementation of AI platforms within the public healthcare sector.

Competitor analysis for Spectral AI, Inc.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Company Value to EBITDA|Quantum-Si Corp - EV/EBITDA Multiple|NNOX (Nano-X Imaging Ltd) - Enterprise Value to Operating Income Before Depreciation|QTRX: EV/EBITDA Multiple|MASS - Total Company Value to Operating Income Before Depreciation Ratio|CV (CapsoVision, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MaxCyte Inc. (MXCT)|EV/EBITDA Multiple RPID|EV/EBITDA Multiple Seer Bio (SEER)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Hyperfine, Inc. HYPR|fonar.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|DXR: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)